PT817858E - Preparacoes fotoprotectoras que compreendem derivados de triazina - Google Patents

Preparacoes fotoprotectoras que compreendem derivados de triazina

Info

Publication number
PT817858E
PT817858E PT96907398T PT96907398T PT817858E PT 817858 E PT817858 E PT 817858E PT 96907398 T PT96907398 T PT 96907398T PT 96907398 T PT96907398 T PT 96907398T PT 817858 E PT817858 E PT 817858E
Authority
PT
Portugal
Prior art keywords
vectors
relates
present
understand
derivatives
Prior art date
Application number
PT96907398T
Other languages
English (en)
Inventor
Robert Michael Saller
Walter H Gunzburg
David Winder
Original Assignee
Gsf Forschungszentrum Umwelt U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt U filed Critical Gsf Forschungszentrum Umwelt U
Publication of PT817858E publication Critical patent/PT817858E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT96907398T 1995-03-09 1996-03-08 Preparacoes fotoprotectoras que compreendem derivados de triazina PT817858E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK24395 1995-03-09

Publications (1)

Publication Number Publication Date
PT817858E true PT817858E (pt) 2003-09-30

Family

ID=8091353

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96907398T PT817858E (pt) 1995-03-09 1996-03-08 Preparacoes fotoprotectoras que compreendem derivados de triazina

Country Status (10)

Country Link
US (1) US7022319B1 (pt)
EP (1) EP0817858B1 (pt)
JP (1) JP3908274B2 (pt)
AT (1) ATE238427T1 (pt)
AU (1) AU5103996A (pt)
DE (1) DE69627644T2 (pt)
DK (1) DK0817858T3 (pt)
ES (1) ES2198479T3 (pt)
PT (1) PT817858E (pt)
WO (1) WO1996028563A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9701544A (es) * 1994-09-02 1998-03-31 Gsf Forschungszentrum Umwelt Vectores de expresion retrovirales dirigidos, no autoinactivantes.
GB9621680D0 (en) * 1996-10-17 1996-12-11 Oxford Biomedica Ltd Lentiviral vectors
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
GB9720465D0 (en) 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
CA2304983A1 (en) 1997-09-24 1999-04-01 The Regents Of The University Of California Non-primate lentiviral vectors and packaging systems
GB2344592B (en) * 1997-09-25 2002-09-11 Oxford Biomedica Ltd Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
ATE278029T1 (de) 1998-01-06 2004-10-15 Inst Virologie Teilrechtsfaehi Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
GB9817693D0 (en) * 1998-08-14 1998-10-07 Bridgehead Technologies Limite Virally-mediated targeting of drugs and genetic material
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
GB9906615D0 (en) * 1999-03-22 1999-05-19 Oxford Biomedica Ltd Vector
EP2167688A4 (en) * 2007-06-12 2010-07-28 Univ Case Western Reserve TARGETED CELL DEATH
EP2454276A4 (en) * 2008-07-17 2013-07-10 Inter K Pty Ltd THERAPEUTIC AGENTS

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970006154B1 (ko) * 1987-07-06 1997-04-24 루이지아나 스테이트 유니버시티 아그리컬춰럴 앤드 메카니칼 컬리지 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유아세포와 임파구의 자극
US4822608A (en) 1987-09-14 1989-04-18 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
JPH02504344A (ja) 1988-05-17 1990-12-13 スローン‐ケツテリング・インステイテユート・フオー・キヤンサー・リサーチ レトロウイルスベクター
US5658775A (en) * 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
US5124263A (en) * 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
GB8919607D0 (en) 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
KR970005329B1 (ko) * 1989-12-07 1997-04-15 게에스에프-프로슝첸트룸 퓌르 움벨트 운트 게순드하이트, 게엠베하 포유 동물의 레트로바이러스 감염 치료용 조성물
US6027722A (en) * 1990-10-25 2000-02-22 Nature Technology Corporation Vectors for gene transfer
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
ES2144426T3 (es) * 1991-10-25 2000-06-16 Sidney Kimmel Cancer Ct Terapia genica linfoquimica del cancer en combinacion con antigenos tumorales.
US5302706A (en) 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
WO1995000178A1 (en) 1993-06-25 1995-01-05 Board Of Regents, The University Of Texas System Pore-forming and superantigen encoding toxin cassettes for gene therapy
WO1995001095A1 (en) * 1993-06-30 1995-01-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Transformed eukaryotic cells, and transposon-based transformation vectors
AU692794B2 (en) 1993-08-30 1998-06-18 Baylor College Of Medicine Senescent cell-derived inhibitors of DNA synthesis
WO1995013375A1 (en) 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
MX9701544A (es) * 1994-09-02 1998-03-31 Gsf Forschungszentrum Umwelt Vectores de expresion retrovirales dirigidos, no autoinactivantes.
JPH11508441A (ja) 1995-03-09 1999-07-27 ババリアン・ノルディック・リサーチ・インスティテュート・アクティーゼルスカブ 遺伝子治療用の新規組換えｄｎａベクター
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
WO1997001357A1 (en) 1995-06-27 1997-01-16 Bavarian Nordic Research Institute A/S Encapsulated cells producing viral particles
AU6987696A (en) 1995-09-06 1997-03-27 Bavarian Nordic Research Institute A/S The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
US5863904A (en) 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21
AU1334999A (en) 1997-10-20 1999-05-10 Universita Degli Studi Di Padova A packaging cell line producing siv-pseudotyped mlv
ATE278029T1 (de) 1998-01-06 2004-10-15 Inst Virologie Teilrechtsfaehi Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression

Also Published As

Publication number Publication date
AU5103996A (en) 1996-10-02
DK0817858T3 (da) 2003-08-11
ES2198479T3 (es) 2004-02-01
ATE238427T1 (de) 2003-05-15
US7022319B1 (en) 2006-04-04
JP3908274B2 (ja) 2007-04-25
DE69627644D1 (de) 2003-05-28
JPH11503305A (ja) 1999-03-26
EP0817858B1 (en) 2003-04-23
WO1996028563A1 (en) 1996-09-19
EP0817858A1 (en) 1998-01-14
DE69627644T2 (de) 2004-02-19

Similar Documents

Publication Publication Date Title
PT817858E (pt) Preparacoes fotoprotectoras que compreendem derivados de triazina
FI951138A7 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
DE69830663D1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
HUP9902310A2 (hu) Komplementer adenovírus-vektorrendszerek és sejtvonalak
ATE183515T1 (de) Zusammensetzungen die die hiv replikation inhibieren
ES2053413T3 (es) Peptidos que inducen anticuerpos que neutralizan aislados de vih-1 geneticamente divergentes.
ATE260980T1 (de) Die erzielung hoher titer des rekombinanten aav- vektors
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
EP0710288A4 (en) ADENOVIRAL VECTORS FOR TREATMENT OF HEMOPHILIA
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
RU95115239A (ru) Аналог эритропоэтина
NZ320889A (en) A p35 protein which binds to and inhibits chemokines
HUP0000318A2 (hu) Tumorvakcina és eljárás előállítására
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
BR0312889A (pt) Polipeptìdeo t20 peguilado
FI970892A7 (fi) Ilmentymiseltään kohdennetut retrovirusvektorit, jotka eivät ole itses tään inaktivoivia
IL117194A0 (en) Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them
FI971275A7 (fi) Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekn iset adenovirukset
HUP9802587A2 (hu) Glükózzal indukálható rekombináns virális vektor, ezt tartalmazó gyógyszerkészítmény és ezzel transzformált sejtek
DE69330268D1 (de) Hämoregulierende peptide
ATE296314T1 (de) Peptide des env-gens vom katze immunschwäche- virus und deren verwendung
ATE240349T1 (de) Peptide zur inhibierung von hpv e6-proteinen
NO20022468D0 (no) Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider
WO2022010860A3 (en) Infectious recombinant vesicular stomatitis virus (rvsv) bearing the spike glycoprotein s of sars-cov-2 and uses thereof
PY0101564A (es) Triazine containing anionic compounds useful as antiviral agents